Hirschsprung’s disease

Last updated: April 6, 2026Bookmark

Hirschsprung’s disease is a congenital disorder characterised by the absence of ganglion cells (aganglionosis) in the Meissner and Auerbach plexus of a segment of the distal colon. This is thought to be due to the failure of neural crest cell migration. Aganglionosis leads to chronic functional obstruction. It always extends the distal rectum and can extend proximally for variable lengths.

It affects boys more than girls.

TypeDescription
Short-segment disease (80%)Affects the rectosigmoidal area
Long-segment disease (15 – 20%)Extends proximally to the sigmoid
Total colonic aganglionosis (< 5%)Affects the entire colon. Can involve the small intestine.
Zonal or skip-type (very rare)Segmental involvement with mixed ganglionic and aganglionic segment

Functional classification

ClassificationDescription
Classical Hirschsprung’s diseaseAganglionosis + delayed passage of meconium and obstruction
Hirschsprung’s disease variants (Dysganglionosis spectrum)
Intestinal neuronal dysplasiaHyperplastic ganglia with increased AChE activity
HypoganglionosisA reduced number of ganglion cells
Internal anal sphincter achalasiaNormal ganglia with absent rectoanal inhibitory reflex (RAIR)
Immature gangliaThis is seen in neonates. It can mimic Hirschsprung’s disease
  • Associated conditions
    • Down syndrome (10% of Hirschsprung’s disease cases)
    • Multiple endocrine neoplasia type 2 (MEN2A/B)
    • Waardenburg syndrome (piebaldism, deafness, aganglionosis)
    • Congenital central hypoventilation syndrome (Ondine’s curse)
  • Pathophysiology
    • The enteric nervous system is derived from neural crest cells, which migrate rostrocaudal.
    • Disrupted signaling → failure of neural crest cell migration, proliferation, or differentiation at weeks 5 – 12 of gestation → aganglionosis in the distal bowel
    • Consequences of aganglionosis
      • Loss of inhibitory neurons → failure of relaxation
      • Unopposed excitatory activity due to persistent ACh release → tonic contraction of the aganglionic segment
      • Functional obstruction → progressive dilation of the proximal segment → megacolon
      • Absent recto-anal inhibitory reflex (RAIR – internal sphincter remains contracted when the rectum is distended)
  • Signs and symptoms
    • Failure to pass meconium
    • Abdominal distention
    • Reluctance to fed
    • Bouts of alternating constipation and diarrhoea
      • Constipation is common in older children
    • Hirschsprung-associated enterocolitis (sepsis and toxic megacolon)
      • Fever
      • Bloody stool
      • Explosive diarrhoea
  • Physical examination
  • Differentials
    • Meconium ileus
    • Small left colon syndrome
    • Functional constipation
  • Investigations
    • Abdominal X-Ray
      • Multiple loops of dilated bowel due to distal functional obstruction
      • Air-fluid levels
      • Paucity of rectal gas
    • Contrast enema
      • Narrow bowel segment (aganglionic)
      • Dilated bowel segment (proximal to aganglionic region due to fecal accumulation)
      • Transition zone (occurs later in life)
      • Delayed evacuation of contrast (24 hours)
    • Anorectal manometry
      • Absent rectoanal inhibitory reflex (RAIR), i.e., failure of internal anal sphincter relaxation
    • Rectal suction biopsy or full-thickness biopsy – This is the most accurate test (gold standard)
      • Absence of ganglion cells in the submucosal (Meissner) plexus
      • Hypertrophied nerve trunks
      • Increased acetylcholinesterase activity
    • Screen for associated conditions
  • Treatment
    • Nil per os
    • Intravenous fluids
    • Nasogastric tube for decompression
    • Rectal irrigations for bowel decompression
    • Antibiotics for Hirschsprung-associated enterocolitis
    • Surgery (“Pull-through” procedures)
      • Involves resection of the aganglionic segments and pulling down of the normal ganglionated bowel to the anus
    • Diverting colostomy or ileostomy before primary repair or secondary take-down if there is enterocolitis or sepsis
  • Complications
    • Fecal retention
    • Incontinence
    • Anastomotic breakdown
    • Stricture
    • Hirschsprung-associated enterocolitis (HAEC)
    • Total colonic aganglionosis
    • Other general surgical complications

Pull-through procedures

ProcedureKey IdeaNota bene
Swenson procedureResection of aganglionic bowel + direct coloanal anastomosisCarries an increased risk of pelvic nerve injury
Soave procedurePull-through of ganglionated bowel within a mucosal sleeve. This is the most commonly used procedure.Has less nerve damage but carries the risk of cuff stricture or obstruction
Duhamel procedureThe bowel is pulled behind the rectum (side-to-side anastomosis)Avoids pelvic disection, but can lead to fecal stasis within the blind pouch
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

Your email address will not be published. Required fields are marked *